Fluid
restriction in term neonates with moderate to severe perinatal asphyxia: A
randomised controlled trial
Tomar V.1, Rai R.2, Singh D.K.3
1Dr.Vasudha Tomar, Post Graduate, Department of Pediatrics, M. L.
N. Medical College, Allahabad, 2Dr. Ruchi Rai, Professor, Department
of Pediatrics, M. L. N. Medical College, Allahabad, Current affiliation:
Department of Neonatology-MRH, Super Specialty Pediatric Hospital and Post
Graduate Teaching Institute, Noida, 3Dr. D. K. Singh, Professor,
Department of Pediatrics, M. L. N. Medical College, Allahabad, Current
affiliation: Department of Pediatrics, Super Specialty Pediatric Hospital and
Post Graduate Teaching Institute, Noida, India
Corresponding Author: Dr. Ruchi Rai, Professor, Department of Pediatrics, M. L. N.
Medical College, Allahabad. Email:
ruchiraialld@gmail.com
Abstract
Introduction: Management of newborns who suffer perinatal asphyxia is
primarily based on supportive management, of which fluid and electrolyte
management plays a very important role. We studied the role of restriction of
fluids in the first 72 h in term neonates suffering from moderate to severe
perinatal asphyxia. Methods: Term
newborns with moderate to severe perinatal asphyxia were randomised to receive
full or restricted fluids (25 newborns each) during the first 72 h of life. The
primary outcome measures were mortality and neurological status at discharge. Results: Mortality among the full (FF)
and restricted fluid (RF) groups was not significantly different, 4 in the FF
group and 3 in the RF group with a relative risk (RR) of 1.52 [confidence
interval (CI) 0.38-6.04]. The neurological status at discharge was also
comparable in both the groups with RR (CI) 0.61 (0.22-1.7). Conclusion: Routine restriction of
fluids in term neonates with moderate to severe perinatal asphyxia does not
have any advantage.
Keywords: Cerebral edema, Fluid restriction, Perinatal asphyxia, SIADH
Author Corrected: 26th August 2018 Accepted for Publication: 31st August 2018
Introduction
India is still tackling with the problem of high neonatal mortality rate (NMR), the present NMR being 28 per 1000 live births [1]. Despite advances in perinatal care, one of the common causes of neonatal mortality continues to be perinatal asphyxia. [2,3].Newborns who suffer perinatal asphyxia constitute a major proportion of newborns who need intensive care management immediately after birth[4]. Such neonates not only have high risk of mortality but even if they survive they have poor neurodevelopmental outcomes on long term follow up.Perinatal asphyxia causes serious damage to the neonatal brain and the mechanism of damage is still not completely understood. A search for a definitive treatment to reduce the mortality and poor neurological outcome in these babies has not been very promising. Most of the management modalities that have been tried in asphyxiated neonates have failed to significantly improve survival or neurological outcome. Supportive management remains the mainstay of treatment offered in such babies. One of the components of supportive care is judicious fluid administration to avoid both fluid overload and inadequate blood volume. The major consequence of fluid overload is considered to be cerebral edema, which apparently contributes to neurological damage[5].Fluid restriction has almost universally been used to avoid cerebral edema. But there is no clear evidence to support the benefits of fluid restriction. Fluid restriction in neonates is mostly based on experiences from older children adults [6].
However, as the body
fluid composition of newborns is unique and is different from that at any other
age and the fact that there is simultaneous CNS and renal insult the fluid
management becomes complex.
There are no RCTs in
neonates to refute or support the use of fluid restrictions in perinatal asphyxia
[7,8]. We, therefore conducted this study to look for the effect of fluid
restrictions in the first 72 h of life in term neonates(≥37weeks) suffering
from moderate to severe perinatal asphyxia on the immediate mortality (before
discharge), electrolyte imbalance, seizure activity and renal functions.
Methods
Place of study:
Neonatal intensive care unit of a tertiary care teaching hospital.
Type of study:This
was a randomised control trial done over a period of 12m from July 2014 to June
2015.
The
study was approved by the Institutional ethical committee. A written informed
consent was taken from either of the parents. The inclusion criteria were: i) Newborns
born at term (≥ 37 weeks of gestation), ii) presented within 6 h of birth and
iii) moderate to severe birth asphyxia (Apgar score at 5 min ≤6) [9].
The
exclusion criteria were: i) Newborns presenting with bleeding or shock and ii)
newborns with gross congenital malformations.
Sampling methods:
The newborns fulfilling all the inclusion criteria were randomised, using block
randomization with blocks of 4. Random numbers were generated using a
randomization website (www.randomiser.org).
The babies were randomised into two groups; full fluid (FF) group and the
restricted fluid (RF) group. The allocation was concealed in sequentially
numbered opaque envelopes (SNOSE).
The
primary outcome measures were i) mortality among the study population and ii) neurological
status of the newborns at discharge. The secondary outcome measures were, i)
need for a second anticonvulsant and ii) electrolyte imbalance at 24 h of life.
After
an initial rapid assessment and emergency management, the babies were allocated
to their respective groups. The babies in the full fluid group were started
with the standard fluid protocol i.e. 60ml/kg/d at admission with an increment
of 15 ml/kg/d till 72 h of life. The newborns in the restricted fluid group
were given two third of the total fluid requirement from admission till 72 h of
age. After 72 h of life all the neonates of both groups were administered
fluids according to a similar protocol i.e. normal maintenance fluids with
daily increments without any restrictions upto a maximum of 150 ml/kg/d. Apart
from the volume of fluids in the first 72 h, all the management remained
similar in both groups.
Fluids
given in the first 48 h of age was plain dextrose @ 4-6 mg/kg/min by a syringe
infusion pump. Electrolytes were added after 48 h with sodium (Na+)
@2-3 meq/kg/d and potassium (K+) @2meq/kg/d. Neonates in both the
groups were managed according to standard protocols. All the babies were nursed
under a servo controlled radiant warmer and weighed daily in the morning (pre
feed in case the baby was on feeds) on a digital weighing machine with a sensitivity
of 10g. Urine output was measured in all the babies by a urine collection bag
or catheterisation for first 72 hours. Blood sugar was measured at admission and
thereafter as required. Calcium gluconate (10%) was given to all newborns @ 4
ml/kg/d for 72 h and further if needed.
Serum
Na+, K+, calcium (Ca++), urea, creatinine,
Urinary Na+ and specific gravity (s.g.) were measured at 24 h of age
and then repeated accordingly. Other investigations like hematocrit, serum
bilirubin, cerebrospinal fluid analysis, sepsis screen, blood culture, chest X
ray were done as and when required.
Regular
vital monitoring like temperature, respiratory rate, heart rate, capillary
refill time (CRT), SpO2 were monitored closely. Hypoxic ischaemic
encephalopathy (HIE) staging was done according to the Levene classification
and classified as mild/ moderate/ severe [10].Convulsions were managed
according to standard protocols. Intra venous phenobarbitone was given @ 20
mg/kg (after ruling out other treatable causes like hypocalcemia, hypoglycaemia)
followed by a maintenance of 5 mg/kg/d in 2 divided doses. If needed a repeat
loading dose of phenobarbitone was given @ 10 mg/kgupto a maximum of 40 mg/kg.
Phenytoin was used as a 2nd anticonvulsant if required. Feeding was
started as soon as possible, when the baby was hemodynamically stable and free
from convulsions for 24 h. The babies were discharged when, i) vitals were
stable without any support, ii) they were convulsion free for 72 h and iii)
accepting paladai/ breast feeds.
Babies
going into shock i.e. CRT>3 sec and HR> 160/min and cold extremities (in
absence of hypothermia) were given a fluid bolus of 20 ml/kg over 10 min and
started on full fluids if the baby was in the restricted fluid group. Shock was
further managed as per protocol. Babies having oliguria (urine output (U.O.)
< 1 ml/kg/h were given a bolus of 20 ml/kg of normal saline over 20 min. If
the U.O. output improved to >1 ml/kg/h over next 4 h the baby was shifted to
full fluids (if in restricted fluid group) and labelled as pre renal acute
kidney injury (AKI). If the U.O. did not improve they were labelled as renal
AKI and fluids administered accordingly[11].
At
the time of discharge a detailed neurological examination of the babies was
done and the neurologic status of the baby categorised as normal or abnormal.
The examination included assessment of the sensorium, tone, presence of
seizures and neonatal reflexes. If the neurologically examination was abnormal
then the baby was discharged on oral phenobarbitone.
Statistical analysis:
The analysis was done using the Epi info 7 software.An intention to treat
analysis was followed. The continuous variables were expressed as mean ±
standard deviation and as numbers and percentages for categorical
variables. Student’s t test and chi square/fisher exact test
was used to determine significance for numerical and categorical values respectively.
A p value of < 0.05 was considered as significant.
Results
We
enrolled a total of 50 newborns, 25 each in the FF group and the RF group.
Final analysis of 45 neonates was done as 4newborn in the FF group and 1 in RF
group were discharged on request before the study could be completed [Fig.1]. The
newborns enrolled were comparable in sex distribution and birth weight.
Fig-1:
Flowchart for randomization and follow up
Allocation
Follow
up
Analysis
Mortality among the two groups was
also not significantly different, 4 in the FF group and 3 in the RF group with
a relative risk (RR) of 1.52 [confidence interval (CI) 0.38-6.04]. The
neurological status at discharge was also comparable in both the groups with RR
(CI) 0.61 (0.22-1.7). In each group 7 neonates went into shock, those in the RF
group were shifted to full fluids. Three babies in the FF group and 6 babies
from the RF group had oliguria. The incidence of shock and oliguria was not
significantly different between the two groups [Table I]. Urine output improved
after a fluid bolus in 1 newborn in the FF group and 3 babies in RF group.
Table-I: Outcome parameters
(categorical) in the two groups
Characteristics Full Fluid Group (n=21) Restricted Fluid Group (n=24) p VALUE RR (CI)
[N
(%)] [N (%)]
Expired
[N (%)] 4 (19%) 3 (12.5%)
0.42 1.52 (0.38-6.04)
Abnormal
neurological 4/17 (23.5%) 7/21
(33.3%)
0.33* 0.61(0.22-1.7)
status
at discharge
2nd
anticonvulsant 6 (28.5%) 12 (50%)
0.08 0.5 (0.21-1.17)
Shock 7 (33.3%) 7 (29.1%)
0.76 1.14 (0.47-2.7)
Weight gain on D2 10 (47.6%) 7
(29.1%) 0.78 1.07 (0.62-1.87)
≠Hyponatremia
3(15%) 9(39.1%)
0.07*0.38 (0.12-1.22)
≠↑Urinary
sodium 3(15%)
6(26%)
0.79*0.57 (0.16-2.0)
≠Oliguria 3(15%) 6(26%)
0.3* 0.57 (016-2.0)
*Fisher
exact test; RR relative risk; CI confidence interval
≠N
is 20 in FF and 23 in RF as one baby died in each group before the sample could
be sent
The
electrolyte values at 24 h were similar in both groups [Table II]. The urine
specific gravity was significantly higher in the RF group with a p value of
0.02. Weight gain along with hyponatremia (suggestive of SIADH) was seen in 5
babies (4 from RR group and 1 from FF group) with a RR (CI) of 1.14
(0.93-1.39). Only 2 out of these 5 newborns showed a simultaneous increase in urinary
sodium.
Table-II: Laboratory parameters in
the two groups
Characteristics Full Fluid Group (n=20)* Restricted Fluid Group (n=23)* p VALUE
(Mean ± SD)
(Mean ± SD)
Serum
Na+ (meq/L) 135.6 ± 5.6
133 ±14.5
0.5
Serum
K+ (meq/L) 4.7 ± 0.9 4.7 ± 0.7
0.8
Serum
Ca2+ (mg/dL) 6.02 ± 3.0
5.96 ± 2.6 0.95
Blood
urea (mg/dL) 51.7 ± 29.1
51.9 ± 32
0.9
Serum
Creatinine (mg/dL) 1.06 ± 0.4
0.99 ± 0.5 0.6
Urinary Sodium (meq/L)# 192.4 ± 179
186.6 ± 127
0.9
Urine
specific gravity1 1.011
± 0.006 1.014 ± 0.007 0.02
Urine output (ml/kg/h)
2.1 ± 1
1.7 ± 1
0.2
*N
is 20 in FF and 23 in RF as one baby died in each group before the sample could
be sent
#
normal range 40-220 meq/L/d; 1 normal
range 1.005-1.012; SD standard deviation
Discussion
We
did not find any significant difference in the outcomes of babies with moderate
to severe perinatal asphyxia who received full fluids or restricted fluids.Asphyxiated
neonates are prone to fluid overload and cerebral edema due to i) SIADH which
is manifested as hyponatremia, hypo-osmolarity along with low urine output and
inappropriately concentrated urine ii) acute tubular necrosis (ATN) due to
redistribution of blood to brain, heart and adrenal glands (diving reflex) [12].After
perinatal asphyxia, during the first phase of early cell death, which occurs
within minutes, there is exhaustion of cellular energy stores. Immediate
intervention may give an opportunity to minimize brain damage and restore
oxygen supply and blood circulation. A second phase of damage starts after
several hours which includes mechanisms like free radical injury, intracellular
calcium entry and apoptosis [13,14]. Management in the intensive care unit
largely addresses this second phase and interventions are aimed at blocking
these brain damaging processes. Aim of all interventions is to minimize
mortality and brain damage and simultaneously cause minimal side effects.
Early
management of perinatal asphyxia is extremely crucial to minimize the harm to
the neonatal brain. There has been a constant search for newer modalities which
would reduce the neurological damage. These neuroprotective strategies include
NMDA antagonists, free radical scavengers, anti inflammatory and anti oxidative
drugs [15,-17]. But all these are still only at experimental or research stage
and have not been included in the standard management as yet. The most
promising strategy that has emerged out of all these is induced hypothermia
whether total body cooling or selective head cooling and has become a part of
standard care for neonates with perinatal asphyxia in many centres [18,19]. But
the facility is not available in most of the establishments providing care to
newborns because of costs involvement as well as the lack of trained staff and
infrastructure. Therefore, the mainstay of management of neonates who suffer
from perinatal asphyxia remains supportive. An important unresolved issue in
the supportive care is the amount of fluid to be administered in the initial
period of 48-72 h after birth. As cerebral edema is anticipated, treatment
modalities include measures to minimise edema.Modalities to counter the
cerebral edema which have been tried are corticosteroids, hyperventilation and
osmotic agents (mannitol and glycerol) but none showed promising benefits and
are no longer used [20]. Ramesh et al recommended two third fluid restriction
in presence of hyponatremia till the serum sodium returns to normal [21].
Various
modalities such as allopurinol, calcium channel blockers, corticosteroids,
fluid restriction, head or whole body cooling, hyperbaric oxygen,
hyperventilation, magnesium sulphate, mannitol, opiate antagonists were studied
in a systematic review by McGuire W. [8]. They were not able to find any
systematic review or RCT to study the benefits and harms of fluid restriction
in term or near term babies with perinatal asphyxia. In a Cochrane review
conducted to determine the effect of fluid restriction on short term (mortality
within first 28 d, grade of HIE, electrolyte abnormalities, renal functions and
seizure activity) and long term outcomes (death during first year of life,
CT/MRI changes or severe neurodevelopmental disability at 12 m of age) in term
infants following perinatal asphyxia, the authors found no (RCTs or quasi
randomized) fulfilling their selection criteria [7].
Excessive
fluid restriction may lead to hypotension and dehydration resulting in
decreased cerebral perfusion and in turn aggravating brain damage. This may
also predispose the baby to renal compromise and can lead to pre renal AKI
which may progress to renal AKI. Girish et al studied AKI in perinatal asphyxia
and found 64% neonates to suffer from acute kidney injury [22]. Out of these
78.12% had pre renal AKI and remaining 21.88% had intrinsic AKI. In our study 3
neonates in FF group and 6 neonates in RF group had oliguria i.e. 9 out of 45
(20%). Although the incidence of oliguria was higher in RF group but it was not
significantly different. In the study by Girish et al 63.6% of the babies with AKI
responded to fluid boluses suggesting that optimising/expansion of
intravascular compartment can prevent AKI in many newborns with asphyxia as
well as prevent pre renal AKI to progress to renal AKI.Nouri et al in their
study of renal failure in term babies with birth asphyxia found an incidence of
17.2% [23]. They found renal failure to be related to the severity of
neurological damage.
The
limitation of our study is that we did not follow up the infants to look for
the long term neurologicaloutcome.
Myocardial
contractility is impaired after hypoxic ischaemic insult leading to a decrease
in cardiac output, hypotension and further compromising the cerebral perfusion.
Therefore, maintaining normovolemia is extremely crucial to maintain adequate
perfusion to brain. Moreover, it is now increasingly felt that cerebral edema
may be marker of the brain damage rather than being a cause of it. Therefore,
targeting cerebral edema may not be an important part of the neuroprotective
strategy [5,10].
Conclusion
Routine
restriction of fluids may not have any advantage in term newborns with moderate
to severe perinatal asphyxia. More randomised controlled trials are needed to
make a definite conclusion regarding the standard fluid therapy in newborns
with perinatal asphyxia.
What this study adds to existing knowledge? Restriction of fluids in term babies with perinatal asphyxia may not improve
outcome in terms of mortality or neurological status at the time of discharge.
Author
Contributions: VT was involved
in designing the study, analysis of data and writing the manuscript. RR was
involved in study design, data collection and analysis and critical evaluation of the manuscript.
DKS was involved in collection of data and writing of the manuscript.
References
1.
National Institution for transforming India. Neonatal mortality.
Available from: https://www.niti.gov.in/ Accessed September 19,
2018
2. UNICEF. Neonatal
Health. Available from: https://www.unicef.in/
Accessed September 19, 2018
3.
Lawn JE, Cousens S, Zupan J; et al. 4 million neonatal deaths: when?
Where? Why? Lancet. 2005 Mar 5-11;365(9462):891-900.
doi:10.1016/S0140-6736(05)71048-5.[pubmed]
4. Mmbaga BT, Lie RT,
Olomi R, et al. Cause-specific neonatal mortality in a neonatal care unit in
Northern Tanzania: a registry basedcohort study. BMC Pediatr. 2012 Aug
7;12:116. doi: 10.1186/1471-2431-12-116.[pubmed]
5. Levene MI. Management of the asphyxiated full term infant. Arch Dis Child. 1993 May;68(5 Spec No):612-6.[pubmed]
6. Yu PL, Jin LM, Seaman H, et al. Fluid therapy of acute brain edema in children. Pediatr Neurol. 2000 Apr;22(4):298-301.[pubmed]
7. Kecskes Z, Healy G,
Jensen A. Fluid restriction for term infants with hypoxic-ischaemic
encephalopathy following perinatal asphyxia. Cochrane Database Syst Rev. 2005
Jul 20;(3):CD004337. doi:10.1002/14651858.CD004337.pub2
8. McGuire W. Perinatal asphyxia. BMJ Clin Evid. 2007 Nov 7;2007. pii: 0320.
9. The Apgar
score. Committee opinion No 644. American College of Obstetrician and
Gynaecologists. Obstet Gynaecol 2015;126e:52-55.
10. Cornette
L, Levene MI. The asphyxiated newborn infant. In: Chervenak FA, Levene MI, editors. Fetal and neonatal neurology
and neurosurgery. 4th ed. Edinburgh: Churchil Livingstone; 2008.
p542-587.
11.
Subramanian S, Agarwal R, Deorari AK, et al. Acute renal failure in
neonates. Indian J Pediatr. 2008 Apr;75(4):385-91. doi:
10.1007/s12098-008-0043-4.[pubmed]
12. Hansens AR, Soul JS. Perinatal asphyxia and hypoxemic ischaemic encephalopathy. In: Clohery JP, Eichenwald EC, Hansen AR, Stark AR, editors. Manual of neonatal care. 7th ed.
Philadelphia: Lippincott Williams & Wilkins; 2012.
p. 711-728
13.
Rainaldi MA, Perlman JM. Pathophysiology of Birth Asphyxia. Clin
Perinatol. 2016 Sep;43(3):409-22. doi: 10.1016/j.clp.2016.04.002.[pubmed]
14. Levene MI, Vries
LS. The central nervous system: Hypoxic ischaemic encephalopathy. In: Martin RJ, Fanaroff AA, Walsh
CM, editors. Neonatal-perinatal medicine: diseases of fetus and infant. 9th
ed. Volume 2. Missouri: Elsevier Mosby; 2011. p 952-976.
15.
Wintermark P. Current controversies in newer therapies to treat birth
asphyxia. Int J Pediatr. 2011;2011:848413. doi: 10.1155/2011/848413.
Epub 2011 Nov 17.[pubmed]
16.
Gunes T, Ozturk MA, Koklu E, et al. Effect of allopurinol supplementation on
nitric oxide levels in asphyxiated newborns. Pediatr Neurol. 2007
Jan;36(1):17-24. doi:10.1016/j.pediatrneurol.2006.08.005
18.
Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with
mild systemic hypothermia after neonatal encephalopathy: multicentre
randomised trial.Lancet. 2005 Feb 19-25;365(9460):663-70.
doi:10.1016/S0140-6736(05)17946-X.[pubmed]
19.
Shankaran S, Laptook AR, Ehrenkranz RA, et al. Whole-body hypothermia
for neonates with hypoxic-ischemic encephalopathy.N Engl J Med. 2005
Oct 13;353(15):1574-84. doi:10.1056/NEJMcps050929.[pubmed]
How to cite this article?
Tomar V, Rai R, Singh D.K. Fluid restriction in term neonates with moderate to severe perinatal asphyxia: A randomised controlled trial. Int J Pediatr Res.2018;5(8): 413-418.doi:10.17511/ijpr.2018.8.06.